Proteomics International Laboratories Ltd (ASX:PIQ) Canagliflozin Lowers PromarkerD DKD Risk Prediction Scores
Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to announce results showing a significant reduction in the PromarkerD risk scores of patients with type 2 diabetes after taking the diabetes medicine canagliflozin.